Stefanie V. Junk

434 total citations
9 papers, 19 citations indexed

About

Stefanie V. Junk is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Stefanie V. Junk has authored 9 papers receiving a total of 19 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 3 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Stefanie V. Junk's work include Acute Lymphoblastic Leukemia research (8 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Cancer Genomics and Diagnostics (2 papers). Stefanie V. Junk is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Cancer Genomics and Diagnostics (2 papers). Stefanie V. Junk collaborates with scholars based in Germany, United Kingdom and Austria. Stefanie V. Junk's co-authors include Martin Stanulla, Martin Schrappe, Gunnar Cario, Melchior Lauten, Ralph Scherer, Brigitte Schlegelberger, Nils von Neuhoff, J Alam, Bernd Auber and Agata Pastorczak and has published in prestigious journals such as Blood, International Journal of Cancer and Leukemia.

In The Last Decade

Stefanie V. Junk

7 papers receiving 19 citations

Peers

Stefanie V. Junk
Cesar Najera Guatemala
August Williams United States
Brittany Sandoval United States
Harrison G. Zhang United States
Sanne Noort United States
I-Ming L. Chen United States
Cesar Najera Guatemala
Stefanie V. Junk
Citations per year, relative to Stefanie V. Junk Stefanie V. Junk (= 1×) peers Cesar Najera

Countries citing papers authored by Stefanie V. Junk

Since Specialization
Citations

This map shows the geographic impact of Stefanie V. Junk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie V. Junk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie V. Junk more than expected).

Fields of papers citing papers by Stefanie V. Junk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie V. Junk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie V. Junk. The network helps show where Stefanie V. Junk may publish in the future.

Co-authorship network of co-authors of Stefanie V. Junk

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie V. Junk. A scholar is included among the top collaborators of Stefanie V. Junk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie V. Junk. Stefanie V. Junk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Stoltze, Ulrik Kristoffer, Stefanie V. Junk, Hélène Cavé, et al.. (2025). Overt and covert genetic causes of pediatric acute lymphoblastic leukemia. Leukemia. 39(5). 1031–1045.
2.
Alam, J, Yadavali Siva Prasad, J. G. Manns, et al.. (2025). Germline variants observed in pediatric cancer patients related to hereditary breast and ovarian cancer in adults. International Journal of Cancer. 157(12). 2447–2454.
3.
Wagener, Rabea, Ute Fischer, Anna Hoffmann, et al.. (2024). Hyperdiploid acute lymphoblastic leukemia in children with LZTR1 germline variants. HemaSphere. 8(1). e26–e26. 2 indexed citations
4.
Junk, Stefanie V., Gunnar Schmidt, Martin Zimmermann, et al.. (2024). Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia—a case-control study. Leukemia. 38(4). 887–892. 2 indexed citations
5.
Bartram, Thies, Anja Möricke, Richard S. Houlston, et al.. (2021). Genetic Variation in ABCC4 and CFTR and Acute Pancreatitis during Treatment of Pediatric Acute Lymphoblastic Leukemia. Journal of Clinical Medicine. 10(21). 4815–4815. 2 indexed citations
6.
Hinze, Laura, Stefanie V. Junk, Norman W. Klein, et al.. (2017). Genome-Wide Association Study (GWAS) of High-Risk Minimal Residual Disease and Relapse in B-Cell Acute Lymphoblastic Leukemia on Trial AIEOP-BFM ALL 2000. Blood. 130. 3981–3981. 1 indexed citations
7.
Junk, Stefanie V., Norman W. Klein, Sabine Schreek, et al.. (2017). TP53, ETV6 and RUNX1 Germline Variants in Patients Developing Secondary Neoplasms after Treatment for Childhood Acute Lymphoblastic Leukemia. Blood. 130(Suppl_1). 884–884. 1 indexed citations
8.
Junk, Stefanie V., Gunnar Cario, Martin Stanulla, et al.. (2015). Bortezomib Treatment can Overcome Glucocorticoid Resistance in Childhood B-cell Precursor Acute Lymphoblastic Leukemia Cell Lines. Klinische Pädiatrie. 227(3). 123–130. 10 indexed citations
9.
Junk, Stefanie V., Melchior Lauten, Gunnar Cario, et al.. (2009). Proteasome Inhibitor Bortezomib Induces Apoptosis in Prednisone-Resistant Childhood Acute Lymphoblastic Leukemia Cells.. Blood. 114(22). 991–991. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026